• Schedule 13D/G History

BML Investment Partners, L.P. - Significant Ownership

Signature - Title
BML Investment Partners, L.P. - BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Location
Zionsville, IN
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BML Investment Partners, L.P..

Significant Ownership of BML Investment Partners, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ANTX AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share 19.2% $7.93M 5.75M BML Investment Partners, L.P. Dec 31, 2024
ACRS Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value 13.3% $28.4M 14.3M BML Investment Partners, L.P. Dec 31, 2024
ADVM Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share 11.4% $10.6M 2.37M Leonard Braden Michael Dec 31, 2024
ACHL Achilles Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share 9.97% $5.82M 4.1M BML Investment Partners, L.P. Dec 31, 2024
ELEV Elevation Oncology, Inc. Common stock, par value $0.0001 per share 9.9% $1.53M 5.89M 0% BML Investment Partners, L.P. Apr 16, 2025
EPIX ESSA Pharma Inc. Common Shares, no par value per share 9.5% $7.26M 4.22M BML Investment Partners, L.P. Dec 31, 2024
AVIR Atea Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 8.5% $24.3M 7.22M Leonard Braden Michael Dec 13, 2024
THRD Third Harmonic Bio, Inc. Common Stock, par value $0.0001 per share 8.2% $13.1M 3.72M BML Investment Partners, L.P. Feb 11, 2025
ATHA Athira Pharma Inc. Common Stock, $0.0001 par value 7.8% $969K 3.03M Leonard Braden Michael Dec 31, 2024
IKNA Ikena Oncology, Inc. Common Stock, par value $0.001 per share 7.6% $5.88M 3.65M 0% Leonard Braden Michael Dec 31, 2024
LVTX LAVA Therapeutics N.V. Common shares, par value $0.14 per share 7.4% $2.64M 1.96M BML Investment Partners, L.P. Feb 26, 2025
TIL Instil Bio, Inc. Common Stock, $0.000001 par value per share 6.7% $7.64M 440K Leonard Braden Michael Dec 31, 2024
PMVP PMV Pharmaceuticals, Inc. Common Stock, $0.00001 par value per share 6.7% $4.37M 3.47M BML Investment Partners, L.P. Dec 31, 2024
ORMP ORAMED PHARMACEUTICALS INC. Common Stock par value $0.012 per share 6.55% $6.32M 2.64M BML Investment Partners, L.P. Dec 31, 2024
KZR Kezar Life Sciences, Inc. Common Stock, $0.001 par value 5.1% $284K 369K BML Investment Partners, L.P. Feb 28, 2025
AADI Aadi Bioscience, Inc. Common stock, par value $0.0001 per share 4.98% $3.9M -$255K 2.44M 0% Leonard Braden Michael Mar 5, 2025
TECX Tectonic Therapeutic, Inc. Common Stock, $0.0001 par value per share 0% $0 0 BML Investment Partners, L.P. Dec 31, 2024
CLYM Climb Bio, Inc. Common Stock, par value $0.0001 per share 0% $0 0 BML Investment Partners, L.P. Dec 31, 2024

Schedules 13D/G Reported by BML Investment Partners, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.